2-AG	2-arachidonoylglycerol
6-OHDA	oxidopamine
AA	arachidonic acid
ACEA	arachidonyl-2-chloroethylamide
ACEA	arachidonyl-2-chloroethylamide
ACh	acetylcholine
AD	Alzheimer’s disease
AEA	anandamide, N-arachidonoylethanolamine
Aβ	amyloid-β
BACE1	β-secretase 1
BDNF	brain-derived neurotrophic factor
CB1R	cannabinoid receptor type 1
CB2R	cannabinoid receptor type 2
CBCA	cannabichromenic acid synthase
CBD	cannabidiol
CBDA	cannabinoid acid synthase
CBGA	cannabigerolic acid
CBN	cannabinol
CSF	cerebrospinal fluid
DA	dopamine
DAG	diacylglycerol
DAGLα	diacylglycerol lipase α
DAGLβ	diacylglycerol lipase β
DHA	docosahexaenoic acid
EAE	autoimmune encephalomyelitis
eCB	endocannabinoid
eCBome	endocannabinoidome
ECS	endocannabinoid system
EHA	eicosapentaenoic acid
EPM	elevated plus maze test
FAAH	fatty-acid amide hydrolase
FST	forced swimming test
GABAHPA	γ-aminobutyric acidhypothalamic–pituitary–adrenal
HISE	high-intensity swimming exercise
HRmax	maximum heart rate
LC-PUFAs	long-chain polyunsaturated fatty acids
LPS	lipopolysaccharide
MAGL	monoacylglycerol lipase
MDD	major depressive disorder
MPTP	1-methyl-4-phenyl-l,2,3,6-tetrahydropyridine
MS	multiple sclerosis
NAPE	N-arachidonoyl phosphatidylethanolamine
OEA	N-oleoylethanolamine
PA	physical activity
PD	Parkinson’s disease
PEA	palmitoylethanolamide
PPARα	peroxisome proliferator-activated receptors α
PPARγ	peroxisome proliferator-activated receptors γ
T2DM	type 2 diabetes mellitus
THCA	tetrahydrocannabinolic acid synthase
TRP	transient receptor potential
TRPV1	transient receptor potential vanilloid type 1
VTA	ventral tegmental area
Δ9-THC	Δ9-tetrahydrocannabinol
MVC	maximum ventilatory capacity
Wmax	maximal trial power output